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The first member of the cysteine-rich secretory protein (CRISP) family was described by our laboratory in the rat epididymis, and it is known
as DE or CRISP-1. Since then, numerous CRISPs exhibiting a high amino acid sequence similarity have been identified in animals, plants and
fungi, although their functions remain largely unknown. CRISP-1 proteins are candidates to mediate gamete fusion in the rat, mouse and human
through their binding to complementary sites on the egg surface. To elucidate the molecular mechanisms underlying CRISP-1 function, in the
present work, deletion mutants of protein DE were generated and examined for their ability to bind to the rat egg and interfere with gamete fusion.
Results revealed that the egg-binding ability of DE resides within a 45-amino acid N-terminal region containing the two motifs of the CRISP
family named Signature 1 and Signature 2. Subsequent assays using synthetic peptides and other CRISPs support that the egg-binding site of DE
falls in the 12-amino-acid region corresponding to Signature 2. The interesting finding that the binding site of DE resides in an evolutionarily
conserved region of the molecule provides novel information on the molecular mechanisms underlying CRISP-1 function in gamete fusion with
important implications on the structure–function relationship of other members of the widely distributed CRISP family.
© 2006 Elsevier Inc. All rights reserved.Keywords: Sperm; Egg; Gamete fusion; Fertilization; CRISPIntroduction
The cysteine-rich secretory protein (CRISP) family is a large
group of secreted proteins with molecular weights of about 20–
30 kDa, characterized by the presence of sixteen conserved
cysteine residues, ten of which are clustered in the C-terminal
portion of the molecule. The first member of this evolutionarily
highly conserved family was originally described by our
laboratory in the rat epididymis (Cameo and Blaquier, 1976),
and it is known as protein DE or CRISP-1 (Brooks et al., 1986;
Cohen et al., 2000b). Since then, other members of the CRISP
family have been identified in different mammalian tissues:⁎ Corresponding author. Fax: +54 114 786 2564.
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doi:10.1016/j.ydbio.2006.05.013CRISP-2, also known as Tpx-1, which is expressed in the testis
and seems to be synthesized exclusively in the developing
spermatids (Hardy et al., 1988; Kasahara et al., 1989; O'Bryan
et al., 1998), CRISP-3, with a wider tissue distribution than the
other CRISPs including saliva, prostate, pancreas, pre-B cells,
human neutrophils, thymus, colon and ovary (Haendler et al.,
1993; Kjeldsen et al., 1996; Udby et al., 2005), and the recently
described CRISP-4 which is exclusively expressed in the
epididymidis (Jalkanen et al., 2005). There are also non-
mammalian CRISP proteins in venoms from lizards, snakes and
snails (Morrissette et al., 1995; Milne et al., 2003; Yamazaki
and Morita, 2004) and in eggs and embryos from Xenopus
(Olson et al., 2001; Schambony et al., 2003). More distantly
related proteins such as plant pathogenesis related 1 (PR-1)
proteins, insect allergens (V5) and human Golgi-associated
plant pathogenesis related protein (GAPR-1) exhibit significant
homology to the N-terminal domain of CRISPs but lack the C-
terminal cysteine-rich region (Fernandez et al., 1997; Henriksen
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grouped into the CAP (CRISP/Antigen5/PR-1) superfamily.
Although the number of identified members of this family has
steadily increased during the last years, only few of them have so
far been determined to have a well-characterized biological
function (Rochwerger et al., 1992; Morrissette et al., 1995; Milne
et al., 2003). The first functional role for a CRISP member was
described for epididymal glycoprotein DE (Rochwerger et al.,
1992). After its secretion into the epididymal lumen, DE
associates with the sperm surface during epididymal maturation
(Kohane et al., 1980a,b) and migrates from the dorsal to the
equatorial segment of the acrosome concomitantly with the
occurrence of the acrosome reaction (Rochwerger and Cuasnicu,
1992). The relocation of DE to the equatorial segment, the
fusogenic region of the sperm head, opened the possibility of a
role for this protein in gamete fusion. Results showing that
exposure of zona-free eggs to purified DE produced a significant
reduction in the percentage of egg penetration without affecting
the first step of sperm–egg-binding indicated that this protein
participates in an event subsequent to binding and leading to
fusion, through complementary sites on the egg surface. The DE-
binding sites were localized to the fusogenic area of the egg
surface (Rochwerger et al., 1992), and their temporal expression
on the oocyte correlated with the acquisition of egg fusion ability
during oogenesis (Cohen et al., 1996). DE exhibits high
homology with two other epididymal proteins known as mouse
AEG-1/CRISP-1 (Mizuki and Kasahara, 1992; Eberspaecher et
al., 1995) and human ARP/hCRISP-1 (Hayashi et al., 1996;
Kratzschmar et al., 1996), both of which are also involved in
gamete fusion through binding sites on the surface of the
corresponding eggs (Cohen et al., 2000a, 2001).
The mechanisms by which these epididymal proteins
mediate sperm–egg fusion are still unknown. Structure–
function studies performed by our laboratory using both native
and bacterially expressed recombinant DE showed that the
activity of this protein does not involve carbohydrates and
resides in the polypeptidic region of the molecule (Ellerman et
al., 2002). While disulfide bonds seem to be required for full
biological activity of DE, the analysis of the amino acid
sequence of the protein indicated the lack of functional domains
that could explain its involvement in gamete fusion.
In order to get a better understanding of the molecular
mechanisms underlying the functional role of DE, the present
work was aimed towards the identification of the egg-binding
site within the molecule. For this purpose, deletion mutants of
DE as well as synthetic peptides were examined for their ability
to bind to the egg surface and interfere with gamete fusion.
Interestingly, our results show that the egg-binding site of DE
resides in the region corresponding to an evolutionarily
conserved motif of the CRISP family.Materials and methods
Animals
Adult (age, 90–120 days) male and immature (age, 26–29 days) female
Sprague–Dawley rats were maintained at 23°C with a 12L:12D cycle.Experiments were conducted in accordance with the Guide for Care and Use
of Laboratory Animals approved by the National Institute of Health (NIH).
Production of recombinant DE fragments and synthetic peptides
DE fragments were amplified by PCR using a vector containing the DE full-
length cDNA as template (Ellerman et al., 2002). Several oligonucleotide
primers were designed on the basis of the published sequence of DE (Brooks et
al., 1986; Charest et al., 1988), and restriction sites for different enzymes and/or
a stop codon at the 5′ ends were included:
Primer 1: 5′ ACGGATCCCAAGATACCACTGATGAATG 3′ (BamHI)
Primer 2: 5′ CAACTGCAGACCTGATTATGTGGACTGG 3′ (PstI)
Primer 3: 5′ TCTACAAGCTTAATTGCCACCAGGACAA 3′ (HindIII,
stop)
Primer 4: 5′ AAGGATCCGGTGGCAATTATGTAGGAAG 3′ (BamHI)
Primer 5: 5′ TAGGATCCAGGTGCATTTACAATGACAG 3′ (BamHI)
Primer 6: 5′ TCGACAAGCTTCATTTCTGAGCGTTCACATA 3′ (HindIII,
stop)
Primer 7: 5′ GCGGATCCAAAGTTGGTGTTAAAGTCGGA 3′ (BamHI)
Primer 8: 5′ ACTCTGCAGTTATGGGCCGAAACCGAAGAC 3′ (PstI)
The PCR amplifications were performed using Deep-Vent polymerase (New
England BioLabs, Beverly, MA) in a Perkin-Elmer thermocycler (Norwalk, CT)
(5 cycles at 40°C, plus 25 cycles at 50°C), and the following combinations of
primers were used for each construct: primers 1 and 3 for Fragment 1 (F1);
primers 4 and 2 for Fragment 2 (F2); primers 5 and 2 for Fragment 3 (F3);
primers 5 and 3 for Fragment 4 (F4); primers 1 and 6 for Fragment 5
(F5); primers 5 and 8 for Fragment 6 (F6); and primers 7 and 3 for Fragment 7
(F7). Cloning into the pMAL-c2 vector (New England Biolabs) as well as
protein production and subsequent purification were performed as previously
described (Ellerman et al., 2002). To check the in-frame insertion of the
fragments, each clone was sequenced using malE and M13/pUC sequencing
primers (New England BioLabs) which anneal outside the insertion site (DNA
Sequencing Facility, BRC, Cornell University, Ithaca, NY). Expression of the
different fragments as maltose-binding protein (MBP)-fused proteins was
analyzed by Western blot using anti-DE or anti-MBP as primary antibodies as
previously described (Ellerman et al., 2002). The molecular weight of the
detected bands corresponded to those expected for each fragment: F1: 60.7 kDa;
F2: 50.4 kDa; F3: 61.2 kDa, F4: 53.5 kDa; F5: 49.3 kDa; F6: 48.5 kDa; F7:
47.5 kDa. MBP, used as control in different experiments, was expressed
following the same procedure.
Biotin-conjugated synthetic peptides were prepared by Yale University
Peptide Synthesis Facility (NewHaven, CT). Peptide 1 (P1): GHYTQVVWNST;
Peptide 2 (P2): FYVCHYCPGGNY; and scrambled Peptide 2 (scP2):
VGCNYGPCHYYF.
Recovery and treatment of gametes
Spermatozoa
Sperm recovered from cauda epididymides were placed in a conical tube,
covered with 2 ml of RFM (Kaplan and Kraicer, 1978) and allowed to swim up
at 37°C (Rochwerger and Cuasnicu, 1992). For capacitation, aliquots of the
upper sperm layer were added to 400 μl of media previously placed in tissue
culture wells (16 mm; Costar, Cambridge, MA), at a final concentration of 0.5–
1 × 106 sperm/ml. Sperm suspensions were then incubated under paraffin oil at
37°C for 5 h in an atmosphere of 5% CO2 in air.
For evaluation of motility, 10 μl of sperm suspension was placed on pre-
warmed slides, and the percentage of motility determined subjectively under a
light microscope.
Eggs
Prepuberal female rats were superovulated by injection (s.c.) of eCG
(equine chorionic gonadotropin, 20 UI; Syntex, Argentina) followed by the
administration (s.c.) of hCG (human chorionic gonadotropin, 25 UI; Sigma)
48 h later. Metaphase II oocytes were collected from the oviducts of
superovulated females 15 h after hCG injection. Cumulus cells were removed
Fig. 1. Biological activity of fragments F1, F2 and F3. (A) Schematic diagram of
the entire rat DE protein and the generated recombinant fragments. The numbers
indicate the first and last residue for each fragment. (B) Zona-free eggs were
incubated with 6 μM MBP, F1, F2 or F3, fixed and subjected to IIF using anti-
MBP as primary antibody. Note the presence of a fluorescent labeling with a
negative area (arrowheads) in those eggs incubated with F1 and F3. Similar
results were obtained when anti-DE was used as primary antibody. Scale
bar = 10 μm. (C) Zona-free eggs were pre-incubated in medium alone (C) or in
medium containing 60 μMMBP, F1, F2 or F3 for 30 min and then inseminated
with capacitated sperm. The percentage of penetrated eggs was determined after
3 h of co-incubation. Each bar represents the mean value of at least three
independent experiments ± SEM. a vs. b, P < 0.05. The number in parentheses
above each bar indicates the percentage of inhibition of the corresponding
treatment compared to control (C).
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hyaluronidase (Sigma, Type IV), and zonae pellucidae were dissolved by
treating the cumulus-free eggs with acid Tyrode's solution (pH 2.5) for 10–20 s
(Rochwerger et al., 1992).
For indirect immunofluorescence (IIF) experiments, zona-free eggs were
incubated for 30 min in RFM containing 6 μM of either recombinant DE
(Ellerman et al., 2002), recombinant fragments, MBP, mouse Tpx-1 (Busso et
al., 2005), human ARP (Cohen et al., 2001) or helothermine (provided by Dr.
Possani) or 6 to 30 μM of the synthetic peptides. For experiments involving the
effect of different molecules on sperm–egg fusion, zona-free eggs were
incubated in medium alone or containing different concentrations of either the
recombinant proteins or fragments, or peptides (dissolved in dimethyl sulfoxide
(DMSO)), for 30 min prior to insemination.
Indirect immunofluorescence
Eggs incubated with either proteins, fragments or peptides were fixed in 2%
paraformaldehyde in PBS for 45 min at room temperature and then washed
several times with PBS containing 4 mg/ml BSA (PBS–BSA 4). For detection
of recombinant DE or DE fragments, fixed eggs were incubated in 5% normal
goat serum (NGS) in PBS–BSA 4 for 30 min at 37°C and then exposed to either
anti-DE (Kohane et al., 1983) (1:50 in 1% NGS) or anti-MBP (1:100). The
same steps were followed for the rest of the proteins tested using the
corresponding antibodies: anti-TPX1 (1:100, (Busso et al., 2005)), anti-ARP
(1:100, (Cohen et al., 2001)), anti-helothermine (1:100, provided by Dr.
Possani). All incubations were carried out at 37°C for 1 h. After washing 3
times in PBS–BSA 4, eggs were incubated for 30 min at 37°C in FITC-
conjugated goat anti-rabbit antibody (1:50 in PBS–BSA 4; Sigma). For
detection of synthetic peptides, fixed eggs were washed in PBS–BSA 4 and
incubated with goat anti-biotin antibody (1:100 in PBS–BSA 4; Vector
Laboratories Inc., Burlingame, CA) for 1 h at 37°C. After washing, eggs were
incubated with FITC-conjugated rabbit anti-goat antibody (1:100 in PBS–BSA
4; Sigma). In all cases, eggs were washed, mounted in 90% glycerol in PBS and
examined with a Nikon Optiphot microscope (Nikon, Tokyo, Japan) equipped
with epifluorescence optics (250×).
Evaluation of sperm–egg fusion
Sperm–egg fusion was evaluated by one of the following assays:
(a) Sperm–egg penetration assay: capacitated sperm were added to treated
zona-free eggs at a final concentration of 0.5–2 × 105 cells/ml, and gametes were
co-incubated for 3 h at 37°C in an atmosphere of 5% CO2 in air. Eggs were then
washed in fresh medium to remove loosely adherent sperm, mounted on slides
and analyzed for evidence of sperm penetration under a phase-contrast
microscope (400×). Eggs were considered penetrated if a decondensing sperm
head or two pronuclei and a sperm tail were present in the ooplasm.
(b) Hoechst dye transfer technique: this technique was performed as
previously described (Cohen et al., 1996). Briefly, zona-free eggs were
incubated in 500 μl of fresh RFM containing 1 μg/ml Hoechst 33342
(Sigma). After 5 min incubation at 37°C, eggs were washed four times for
10 min in 500 μl of fresh medium and then exposed to the fragments. After
30 min, eggs were inseminated with capacitated spermatozoa (0.5–2.0 × 105
cells/ml) and gametes were co-incubated for 30 min. Eggs were then fixed with
2% paraformaldehyde in PBS, washed, mounted on slides and examined under a
UV microscope for evidence of sperm–egg fusion. An egg was considered to
have fused with sperm when at least one brightly stained sperm nucleus could be
observed on its surface. The validity of the dye transfer technique was tested by
inseminating zona-free eggs in Ca2+-free medium, a condition under which
fusion does not occur (Yanagimachi, 1978). For evaluation of the effect of F7 on
egg penetrability, Hoechst-loaded eggs were exposed to the fragment for 30 min,
washed, transferred to a drop of fresh medium and then inseminated as described
above.
Statistical analysis
The percentages of egg penetration and fusion as well as spermmotility were
analyzed by chi-square test. Results were considered to be significantly different
at P < 0.05.Results
The DE-egg-binding ability is within the N-terminal domain of
the molecule
Considering that the amino acid sequence of rat DE lacks
known functional domains that could explain its role in gamete
Fig. 2. Biological activity of fragments F4 and F5. (A) Schematic diagram of the
generated fragments. The numbers indicate the first and last residue
corresponding to each fragment. (B) Zona-free eggs were incubated with
6 μM F4 or F5, fixed and subjected to IIF using anti-MBP as primary antibody.
The arrowhead shows the negative area. Scale bar = 10 μm. (C) Zona-free eggs
were pre-incubated in medium alone (C) or in medium containing 60 μMF2, F3,
F4 or F5 for 30 min and then inseminated with capacitated sperm. The
percentage of penetrated eggs was determined after 3 h of co-incubation. Each
bar represents the mean value of at least three independent experiments ± SEM.
a vs. b, P < 0.05. The number in parentheses above each bar indicates the
percentage of inhibition of the corresponding treatment compared to control (C).
Fig. 3. Biological activity of fragments F6 and F7. (A) Schematic diagram of the
generated fragments. The numbers indicate the first and last residue contained in
each construct. (B) Zona-free eggs were incubated with 6 μM F4, F5, F6 or F7,
fixed and subjected to IIF using anti-MBP as primary antibody. The arrowheads
show the negative area in the eggs. Scale bar = 10 μm. (C) Zona-free eggs pre-
loaded with Hoechst 33342 (1 μg/ml) were incubated for 30 min in medium
alone (C) or in medium containing either different concentrations of F7 (6 to
60 μM) or 60 μM F6 and then inseminated with capacitated sperm. After 30 min
of gamete co-incubation, eggs were fixed, mounted on slides and examined
under UVmicroscope for evidence of sperm–egg fusion. Each bar represents the
mean value of three independent experiments ± SEM. a vs. b, P < 0.05; a vs. c,
P < 0.001. The numbers in parentheses above each bar indicate the percentage of
inhibition compared to control (C).
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based on the structural domains previously described for the
recombinant mouse DE homologue (Eberspaecher et al., 1995).
The structural analysis of this murine protein reveals the
presence of a loose N-terminal domain, covering 75% of the
protein and containing three disulfide bonds, and a compact C-
terminal domain with the remaining ten conserved cysteines. In
view of this, the following recombinant fragments were
generated: Fragment 1 (F1), spanning from amino acid 1 to
158, corresponding to the N-terminal domain of DE, Fragment
2 (F2) (156–227), corresponding to the C-terminal domain, and
Fragment 3 (F3) (62–227), containing the 16 cysteines of the
molecule (Fig. 1A).
In order to examine the egg-binding ability of the generated
fragments, rat zona-free eggs were incubated with equimolar
concentrations (6 μM) of each fragment or MBP as a control
and then fixed and subjected to IIF using anti-DE or anti-MBP
as primary antibodies. Results shown in Fig. 1B indicated that,
while eggs incubated with MBP did not exhibit fluorescentstaining, those incubated with F1 or F3 showed the same
fluorescent pattern previously described for the entire recom-
binant DE protein, i.e. a clear labeling localized over the egg
surface with the exception of an area that remained unstained.
By contrast, eggs incubated with F2 were completely unlabeled
as the controls.
To establish whether binding of F1 and F3 to the eggs was
capable of inhibiting gamete fusion, zona-free eggs were pre-
incubated with each fragment, inseminated with rat capacitated
sperm and then examined for evidence of sperm incorporation
into the ooplasm, an unequivocal evidence of the occurrence of
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concentration previously used for IIF (6 μM), none of them
either individually or combined with each other was able to
inhibit egg penetration (data not shown). However, when used
at 60 μM, both F1 and F3 produced a significant reduction in the
percentage of penetrated eggs compared to the control, not
observed in the presence of MBP or F2 (Fig. 1C). These results
indicated that F1 as well as F3 were able to both bind to the egg
surface and inhibit sperm–egg fusion.
The DE-egg-binding ability resides in a 45-amino-acid region
The finding that the two fragments capable of binding to the
egg, F1 and F3, shared an amino acid region led us to generate
Fragment 4 (F4), corresponding to this region in common (62Fig. 4. Design and egg-binding ability of P1 and P2. (A) Signature 1 and Signature 2
acid sequences corresponding to Peptides 1 and 2 are shown in white. Asterisks ind
30 μM of biotinylated P1, P2 or scP2, fixed and subjected to IIF using anti-biotin as p
(arrowhead) in eggs incubated with P2. Scale bar = 10 μm. (C) Zona-free eggs wer
medium containing 60 μM P1, P2 or scP2 for 30 min and then inseminated with capa
incubation. Each bar represents the mean value of four experiments ± SEM. a vs. b, P
number in parentheses above the bar indicates the percentage of inhibition of P2 coto 158). As a control, we generated Fragment 5 (F5)
corresponding to the portion of F1 not present in F3 (1 to 62)
(Fig. 2A).
Evaluation of the egg-binding ability of these two
fragments by IIF indicated that, while eggs exposed to
6 μM F5 did not show fluorescent labeling, those incubated
with the same concentration of F4 showed a strong fluorescent
labeling similar to that observed with F1 and F3 (Fig. 2B).
These results indicated that the egg-binding ability of DE was
contained within the 97-amino-acid region corresponding to
F4. To confirm that binding of F4 to the egg was also capable
of inhibiting gamete fusion, a sperm–egg fusion assay was
performed in the presence of F4 or F5 using F2 and F3 as
negative and positive controls, respectively. As shown in Fig.
2C, while the presence of 60 μM F5 or F2 did not producecontaining regions of CAP representative members are boxed in gray. The amino
icate complete identity of all proteins. (B) Zona-free eggs were incubated with
rimary antibody. Note the presence of a fluorescent labeling with a negative area
e pre-incubated in either medium alone (C), medium containing 1% DMSO or
citated sperm. The percentage of penetrated eggs was determined after 3 h of co-
< 0.0001, b vs. c, P < 0.001, a vs. c, P > 0.05 (not significantly different). The
mpared to control (C).
Fig. 5. Egg-binding ability of CRISP proteins. Zona-free rat eggs were incubated
with 6 μM of rat recombinant DE (DE), mouse recombinant Tpx-1 (TPX-1),
human recombinant ARP (ARP) or helothermine (HLTX) for 30 min, fixed and
subjected to IIF using anti-DE, anti-TPX-1, anti-ARP or anti-helothermine as
primary antibodies, respectively. Note the presence of a fluorescent labeling
with a negative area (arrowheads) in eggs incubated with DE or Tpx-1. Scale
bar = 10 μm.
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medium alone, the presence of an equimolar concentration of
F4 produced a significant reduction in the percentage of
penetrated eggs, similar to that observed for eggs incubated
with F3.
To examine in more detail the egg-binding ability of F4, two
new recombinant fragments, F6 (62 to 116) and F7 (114 to 158),
were generated (Fig. 3A) and examined for their ability to bind
to the egg surface by IIF using F4 and F5 as controls. Results
showed that, while oocytes incubated with F6 were completely
negative, those incubated with F7 presented a fluorescent
labeling similar to that observed with F4 (Fig. 3B).
Having established the ability of F7 to recognize and bind
to the egg surface, sperm–egg fusion assays were performed in
the presence of this fragment to test its ability to interfere with
gamete fusion. In this case, however, a detrimental effect of F7
(60 μM) on sperm motility was observed at the end of the 3 h
co-incubation period. In view of this, lower concentrations of
F7 were tested, and sperm–egg fusion was examined by the
Hoechst dye transfer technique which specifically evaluates
the occurrence of gamete fusion after only a 30 min co-
incubation period. Under these conditions, F7 did not affect
sperm motility at any of the concentrations tested (i.e. F7
(60 μM): 55% ± 5 vs. C: 63% ± 6, NS) and produced a
significant and concentration-dependent reduction in the
percentage of eggs with fused sperm not observed by exposure
to F6 (Fig. 3C). When the fusion inhibitory ability of F2 and
F4 was evaluated by this technique, results consistent with
those previously observed with the egg penetration assay were
obtained (data not shown).
Considering the detrimental effect of F7 on sperm motility,
experiments were performed to exclude the possibility that the
inhibitory effect of F7 on gamete fusion was due to a toxic effect
of the fragment on the eggs. For this purpose, zona-free eggs
were incubated for 30 min in medium containing 60 μM F7 or
in medium alone as a control, washed and then inseminated with
capacitated sperm. Evaluation of gamete fusion by the Hoechst
dye transfer technique indicated no difference between groups
in the percentage of eggs with fused sperm (F7 and then
washed: 80 ± 9, C: 96 ± 6; n = 3, NS).
The DE-egg-binding ability is located in Signature 2 of the
CRISP family
The results obtained supported the idea that the biological
activity of DE would reside in the 45-residue region spanning
from amino acid 114 to 158. The analysis of this region revealed
that it contains two motifs, denominated Signature 1 and
Signature 2 and recognized by the PROSITE database as feature
motifs of the CAP superfamily (Fig. 4A). To investigate whether
these motifs were involved in the egg-binding ability of F7, two
synthetic biotinylated peptides with the amino acid sequences
corresponding to Signature 1 and Signature 2 in DE were
produced: Peptide 1 (P1): GHYTQVVWNST and Peptide 2
(P2): FYVCHYCPGGNY (Fig. 4A). The ability of P1 and P2 to
bind to the egg surface was tested by incubation of zona-free
eggs with different concentrations of the peptides (6, 15 and30 μM), fixation and exposure to an anti-biotin antibody and a
corresponding FITC-conjugated secondary antibody. Results
showed a complete negative labeling of eggs incubated with P1
at all concentrations tested (Fig. 4B). On the other hand, eggs
incubated with 15 and 30 μMP2 presented the strong fluorescent
labeling previously observed for all the active fragments. To
examine whether the sequence of P2 was critical for its activity, a
scrambled P2 peptide was synthesized (scP2: VGCNYGP-
CHYYF) and used in IIF assays. In this case, with the exception
of few fluorescent spots, no labeling on the egg surface was
observed at any concentration (Fig. 4B). To examine whether the
binding of P2 to the egg was capable of interfering with gamete
interaction, sperm–egg fusion assays were performed in the
presence of P1, P2 and scP2.When the peptides were tested at 15
or 30 μM, none of them was able to inhibit egg penetration (data
not shown). When used at 60 μM, P1 and scP2 did not produce
any effect on egg penetration compared to controls (medium
alone or medium with DMSO), while P2 produced a significant
reduction in the percentage of penetrated eggs (Fig. 4C).
These results strongly suggested that the ability of DE to
bind to the egg surface resides in the 12-amino-acid region
corresponding to Signature 2 of the CRISP family. To study the
specificity of this interaction, we analyzed the ability of several
CRISP proteins to interact with rat eggs as well as the amino
acid sequence of their corresponding Signature 2 regions. As
shown in Fig. 5, while mouse Tpx-1 was capable of binding to
the rat egg, human ARP and helothermine were unable to
recognize the rodent gamete. In correlation with this, the
Signature 2 region presented only two substitutions in mouse
Tpx-1 and four in both human ARP and helothermine, when
compared to Signature 2 in rat DE (Table 1). The same analysis
was applied to previous data indicating that rat DE is able to
Table 1
Analysis of the egg-binding ability of CRISP proteins in correlation with the amino acid sequence of their Signature 2 regions
CRISP protein Egg Egg-binding
ability a
Signature 2 sequence
in CRISP proteins
(12 aa) b
No. of different
aa compared
to rat DE
Rat DE/CRISP-1 Rat + FYVCHYCPGGNY –
Mouse Tpx-1/CRISP-2 Rat + FYVCHYCPMGNN 2/12
Human ARP Rat − LYVCHYCHEGND 4/12
Helothermine Rat − YQVCQYCPGGNI 4/12
Rat DE/CRISP-1 Mouse + YYVCHYCPVGNYc 2/12
Rat DE/CRISP-1 Human − LYVCHYCHEGNDd 4/12
a Zona-free eggs were exposed to 6 μM of each tested protein, fixed and then subjected to IIF using the corresponding antibodies (anti-DE, anti-TPX1, anti-ARP,
anti-helothermine or anti-MBP).
b The amino acids different to those in rat DE Signature 2 are underlined.
c The sequence shown corresponds to Signature 2 in mouse AEG protein.
d The sequence shown corresponds to Signature 2 in human ARP protein.
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2001). In this case, the comparison revealed that the Signature 2
sequence in rat DE presents only two substitutions (one of them
by a conservative amino acid) when compared to that of its
mouse homologue (protein AEG) and four substitutions when
compared to human ARP (Table 1).
Discussion
CRISPs are found across a broad variety of living forms and
exhibit diverse biological functions. However, the molecular
mechanisms underlying these functions remain unknown for
most of the CRISP family members. One of these proteins is
epididymal glycoprotein DE, a candidate molecule to mediate
sperm–egg fusion through its binding to complementary sites
on the egg surface (Rochwerger et al., 1992). To elucidate the
molecular mechanisms involved in this interaction, in the
present work, a series of recombinant fragments of DE were
expressed in a prokaryotic system and evaluated for their ability
to both bind to the egg surface and interfere with gamete fusion.
IIF and sperm–egg fusion experiments using the first series of
fragments (F1–F3) revealed that the egg-binding ability of DE
would be contained within the N-terminal domain of the
molecule. Subsequent experiments using a new series of
recombinant fragments (F4–F7) circumscribed this activity to
a region of 45 amino acids (114–158) within this domain.
Eggs incubated with those fragments capable of binding to
their surface (F1, F3, F4, F7) exhibited the fluorescent patterns
previously observed for both native and entire recombinant DE
(Rochwerger et al., 1992; Ellerman et al., 2002). In all cases, the
fragments capable of binding to the egg surface were also able
to compete with sperm and inhibit gamete fusion while those
unable to bind to the egg (F2, F5, F6) also failed to interfere
with gamete interaction. The consistent correlation between
these two parameters supports the results obtained and validates
the use of these biological assays for evaluation of DE activity.
The observation that a higher concentration of fragments was
required to inhibit gamete fusion compared to that used for the
entire recombinant protein suggests that other regions of the
molecule, although not essential, might be contributing to the
proper configuration of the egg-binding site.The analysis of the 45-amino-acid region exhibiting the egg-
binding domain revealed that this fragment contained the two
hallmark motifs of the CAP superfamily: Signature 1 and
Signature 2. The use of synthetic peptides corresponding to
each of these motifs (P1 and P2, respectively) in IIF and sperm–
egg fusion assays indicated that P2 but not P1 was capable of
binding to the egg and interfering with gamete fusion. The lack of
both egg labeling and fusion inhibition observed with a peptide
containing the same amino acids than P2 but in a different order
(scrambled P2) confirmed the relevance of this region for the
binding of DE to the egg.
Together, the results obtained using both the recombinant
fragments and the synthetic peptides indicated that the activity
of DE resides in the 12-amino-acid region corresponding to
Signature 2. To our knowledge, this is the first work describing
a functional role for the motif of the CRISP family and
succeeding in delimiting the activity of a CRISP protein to such
a small region. This result becomes particularly interesting
considering that DE has been shown to be a good candidate for
contraceptive technique development. Evidence from our
laboratory indicated that immunization of male and female
rats with purified DE (Cuasnicú et al., 1990; Ellerman et al.,
1998) or the recombinant protein (unpublished results) leads to
an efficient contraceptive effect in both sexes. Thus, the finding
that the activity of DE resides in only 12 amino acids represents
an important contribution for the future design of new and safer
fertility regulating methods.
The recently reported crystal structure of a CRISP family
member, stecrisp, revealed that this protein contains two domains:
a plant pathogenesis-related domain (PR-1) and a cysteine-rich
domain (CRD), connected by a short hinge (Guo et al., 2005). The
significant similarity in CRISP familymembers ensures that other
CRISPs will possess very similar three-dimensional structures as
stecrisp, the reason why the extendedN-terminal and the compact
C-terminal domains of these proteins are now also referred to as
PR-1 and CRD, respectively. According to this, our results
indicated that the egg-binding ability of DE resides within the PR-
1 domain. Similar results were reported for Tpx-1/CRISP-2, a
testicular homologue of DE proposed tomediate binding between
spermatogenic and Sertoli cells through its 101 N-terminal amino
acid residues (Maeda et al., 1998). Nevertheless, the involvement
Fig. 6. Schematic diagram illustrating the structural domains of CRISP proteins
and their relationship with proposed functional activities. CRISP members
contain a plant pathogenesis-related (PR-1) domain and a cysteine-rich domain
(CRD), connected by a short hinge. The two evolutionarily conserved regions of
the CRISP family, named Signature 1 (S1) and Signature 2 (S2), are located
within the PR-1 domain. Based on the results of the present work, the egg-
binding site of DE resides in S2. The proposed functions for CRISP members
include an ion channel regulatory activity in the CRD, and both a protease
activity and a membrane-interacting activity, in the PR-1 domain.
235D.A. Ellerman et al. / Developmental Biology 297 (2006) 228–237of the CRD domain in other potential functions of DE cannot be
excluded. Recent evidence indicates that CRISP proteins from
snake venoms (Yamazaki and Morita, 2004) as well as mouse
Tpx-1/CRISP-2 (Gibbs et al., 2006) possess an ion channel
regulatory activity located in a region of the CRD. In this regard, it
is interesting to mention that DE has been shown to have an
inhibitory activity on sperm protein tyrosine phosphorylation
(Roberts et al., 2003), a capacitation-associated event which
depends on the regulation of several ion channels (Visconti et al.,
2002). In view of the existence of a population of DE loosely
associated to sperm which is released from the cell during
capacitation (Cohen et al., 2000b), it is possible that DE also acts
as a decapacitation factor, regulating ion channels through its
cysteine-rich domain.
The crystallographic analysis of several PR-1 containing
proteins including tomato P14a (Fernandez et al., 1997), vespid
Ves v 5 (Henriksen et al., 2001), recombinant GAPR-1 (Serrano
et al., 2004) and snake venom stecrisp (Guo et al., 2005) revealed
a unique α–β–α sandwich fold of PR-1 domain and a cleft with
two highly conserved histidines and glutamates suggested as a
putative active site. Moreover, recent evidence indicating that
Tex31, a snail PR-1 protein, has a proteolytic activity (Milne et
al., 2003) implied the possibility of PR-1 domain as an enzymatic
module. The failure to identify enzymatic activities in other
CRISPs (Guo et al., 2005), however, opened the possibility of
additional functions for this domain. In this regard, our findings
indicating that the egg membrane binding ability of DE is within
the PR-1 domain and localized in a region different from the
proposed putative active site strongly support the idea that a great
variance of functions and active sites may be present in the PR-1
domain. Thus, although sharing a common structural organiza-
tion, it is likely that different members of this family have
evolved to perform a variety of functions that rely on different
regions of the molecule, i.e. the ion channel regulatory activity in
the CRD, and both the protease activity and the membrane-
interacting activity (this work) in the PR-1 domain (Fig. 6). The
relevance of the highly conserved three-dimensional structure of
CRISP members for these different functions remains to be
established.Results from our laboratory indicated that, as rat DE, the
mouse and human epididymal homologues also play a role in
gamete fusion (Cohen et al., 2000a, 2001). Moreover, we have
recently described that human TPX1 would participate in this
event of the fertilization process (Busso et al., 2005). Since all
these proteins are closely related members of the CRISP family
with a common biological activity, it is likely that they operate
through a similar molecular mechanism. However, the finding
that the egg-binding ability of DE corresponds to a highly
conserved sequence in these proteins raised the question about
how this common region might possess the necessary
specificity for interacting with the different eggs. To address
this issue, the ability of several CRISPs to bind to the egg was
analyzed in correlation with the amino acid sequence of their
corresponding Signature 2 regions. This analysis revealed that,
in those cases where a protein was able to bind to the egg of
another species (i.e. mouse Tpx-1 to rat eggs or rat DE to mouse
eggs), the sperm proteins from the two species exhibited a
higher sequence homology in their Signature 2 region than that
observed in those cases where the proteins were unable to
interact with the eggs (i.e. human ARP to rat egg, helothermine
to rat egg, DE to human egg). These observations support the
participation of Signature 2 in gamete fusion and suggest that
differences in the amino acid sequence of this region may be
responsible for the specificity of the binding of each CRISP to
its target egg.
In addition to the interaction of these CRISP proteins with the
egg, other members of the CAP superfamily have been proposed
to associate with the membrane of different cells i.e. Na-ASP-2
with phagocytes (Ehlers, 2000; Asojo et al., 2005), XCRISP with
hatching gland cells (Schambony et al., 2003), allurin with sperm
(Olson et al., 2001). However, the molecular mechanisms
involved in these interactions remain unknown. The results of
the present work open the possibility that the conserved Signature
2 region plays a similar role in the function of other proteins of the
family known to interact with cell membranes in different
biological systems.
In conclusion, the interesting finding that the egg-binding
ability of DE resides in an evolutionarily conserved region of the
molecule provides novel information on the molecular mechan-
isms underlying the role of CRISP-1 proteins in mammalian
gamete fusion with potential implications on the structure–
function relationship of other members of a widely distributed
family of proteins.
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